Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Vonend

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
MMW Fortschritte Der Medizin|December 4, 2014
[Uncontrolled blood pressure despite my numerous pills]O Vonend
Current Hypertension Reports|February 11, 2017
Multidisciplinary Approach in the Treatment of Resistant HypertensionS A Potthoff, O Vonend
Deutsche Medizinische Wochenschrift (1946)|November 17, 2006
[Normokalemic primary hyperaldosteronism]O Vonend, L C Rump
Deutsche Medizinische Wochenschrift (1946)|August 16, 2012
[77-year-old patient with unusual 24-hour blood pressure profile]S Kücükköylü, O Vonend, L C Rump
Journal of the American Society of Nephrology : JASN|June 11, 1999
Neuropeptide Y and ATP interact to control renovascular resistance in the ratV Oberhauser, O Vonend, L C Rump
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 5, 2010
Familial hyperaldosteronism I-IIII Quack, O Vonend, L C Rump
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
ATP release and degradation in the kidney: modulatory role of neuropeptide Y (NPY)L C Rump, O Vonend, V Oberhauser
Deutsche Medizinische Wochenschrift (1946)|November 22, 2012
[Primay hyperaldosteronism--diagnostic and treatment]S A Potthoff, F Beuschlein, O Vonend
Der Internist|October 30, 2012
[Treatment resistant hypertension. Value of a new treatment concept]M Siekierka-Harreis, L C Rump, O Vonend
Transplantation Proceedings|February 23, 2010
Preprocurement pancreas allocation suitability score does not correlate with long-term pancreas graft survivalP Schenker, O Vonend, N Ertas, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
MMW Fortschritte Der Medizin|December 4, 2014
[Uncontrolled blood pressure despite my numerous pills]O Vonend
Current Hypertension Reports|February 11, 2017
Multidisciplinary Approach in the Treatment of Resistant HypertensionS A Potthoff, O Vonend
Deutsche Medizinische Wochenschrift (1946)|November 17, 2006
[Normokalemic primary hyperaldosteronism]O Vonend, L C Rump
Deutsche Medizinische Wochenschrift (1946)|August 16, 2012
[77-year-old patient with unusual 24-hour blood pressure profile]S Kücükköylü, O Vonend, L C Rump
Journal of the American Society of Nephrology : JASN|June 11, 1999
Neuropeptide Y and ATP interact to control renovascular resistance in the ratV Oberhauser, O Vonend, L C Rump
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 5, 2010
Familial hyperaldosteronism I-IIII Quack, O Vonend, L C Rump
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
ATP release and degradation in the kidney: modulatory role of neuropeptide Y (NPY)L C Rump, O Vonend, V Oberhauser
Deutsche Medizinische Wochenschrift (1946)|November 22, 2012
[Primay hyperaldosteronism--diagnostic and treatment]S A Potthoff, F Beuschlein, O Vonend
Der Internist|October 30, 2012
[Treatment resistant hypertension. Value of a new treatment concept]M Siekierka-Harreis, L C Rump, O Vonend
Transplantation Proceedings|February 23, 2010
Preprocurement pancreas allocation suitability score does not correlate with long-term pancreas graft survivalP Schenker, O Vonend, N Ertas, et al.
Pageof 3